Health Promotion and Wellness Program for Adults With Disabling Conditions

January 18, 2022 updated by: Matthew Plow, Case Western Reserve University

Examining the Efficacy of a SystemCHANGE™ Weight Management Intervention in Stroke Survivors and Persons With Chronic Inflammatory Autoimmune/Immune-mediated Diseases

The objective of this study is to conduct a randomized controlled pilot study to examine the efficacy, feasibility and safety of the SystemCHANGE™(SC) health promotion and wellness program in adults with disabling conditions. Particularly, the study will focus on developing a program of research on adapting and testing SC weight management interventions in overweight and obese stroke survivors and persons with chronic inflammatory autoimmune/immune-mediated diseases, specifically those with multiple sclerosis (MS) and rheumatoid arthritis (RA).

Study Overview

Detailed Description

Individuals with disabling conditions, such as stroke, multiple sclerosis, or rheumatoid arthritis, face many barriers to engaging in physical activity, healthy nutritional habits, and good sleep hygiene. This leads to weight gain, de-conditioning, and declines in upper- and lower- extremity function, which makes it even more difficult to engage in healthy behaviors, thereby perpetuating a cycle of functional decline. Developing an effective weight management intervention may be a strategy for disrupting this disabling cycle and reducing the impact of the disease. Fostering a positive social environment may help adults with disabling conditions overcome barriers to engaging in healthy behaviors. SystemCHANGE (SC) is a new behavior change program that uses approaches consistent with social ecological theories and process improvement techniques (i.e. changing the dynamics of a system or group) to increase social support in lifestyle behaviors that promote energy balance. SC focuses on redesigning the social environment using a series of trial-and-error "experiments", which is in contrast to cognitive-behavioral interventions that focus on changing a person's viewpoint of a situation and increasing motivation. In a SC intervention, individuals are taught a set of skills to assist them in incorporating habitual lifestyle behaviors into their daily systems so they succeed despite wavering motivation. The rationale for developing a weight management intervention for these patients is to slow disability progression and prevent secondary conditions.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44106
        • Case Western Reserve University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

26 years to 71 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria Stroke:

  • Physician-confirmed diagnosis of stroke (> 6 weeks)
  • Body mass index between 23 to 45 kg/m2
  • Age 30 to 75 years

Exclusion Criteria Stroke:

  • Pregnant or plans to become pregnant in the next 6 months
  • Current participation in a face-to-face weight management program
  • Uncontrolled diabetes (hospitalization within the prior 6 months)
  • Serious mental illness
  • Thyroid and adrenal gland diseases
  • Inability to walk 3 meters with or without a cane or walker
  • Severe cardiopulmonary disease that limits engagement in physical activity (e.g., myocardial infarction, congestive heart failure, coronary artery bypass grafting or valve replacement during the past three months, serious cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, and pulmonary embolus) or abnormal blood pressure or heart rate response after the 6-Minute Walking Test (e.g., a drop in systolic blood pressure of >10mmHg from baseline)
  • Severe cognitive deficits (Screening questioanire called the Short Orientation Memory-Concentration < 12)
  • Currently taking oral corticosteroids, antipsychotic (except for depression medication), or medications specifically for weight loss
  • 3 or more falls in the past month
  • Bulimia
  • Unable to speak English over the phone
  • Able to eat independently and is not on a special diet because of difficulty in swallowing
  • Unstable weight (gained or lost >10lbs in the last two months)

Inclusion Criteria MS or RA:

  • Physician-confirmed diagnosis of multiple sclerosis or rheumatoid arthritis
  • Body mass index between 23 to 45 kg/m2

Exclusion Criteria MS or RA:

  • Pregnant or plans to become pregnant in the next 6 months
  • Current participation in a face-to-face weight management program
  • Uncontrolled diabetes (hospitalization within the prior 6 months)
  • Serious mental illness
  • Inability to walk 3 meters with or without a cane or walker
  • Severe cardiopulmonary disease that limits engagement in physical activity
  • Severe cognitive deficits (Short Orientation Memory-Concentration < 12)
  • Currently taking oral corticosteroids, antipsychotic (except for depression medication), or medications specifically for weight loss
  • 3 or more falls in the past month
  • Bulimia
  • Unable to speak English
  • Uncontrolled thyroid or adrenal disease (change in type and dosage of medication within the prior 3 months)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SystemCHANGE Group Lifestyle counseling
The SystemCHANGE™ intervention will be delivered over a six-month period involving 12 face-to-face group sessions (1.5 to 2 hours each) held weekly for three months, followed by three monthly "booster calls." Intervention groups include ~10 to 15 patients, and friends and family members are encouraged to attend. Intervention sessions consist of 30-min to 60-min of behavior change activities and 60-min focused on healthy behaviors.
Active Comparator: Phone Lifestyle Counseling
Participants will receive pamphlets that contain information on healthy eating, physical activity, sleep, and symptom management, and will be followed-up with telephone calls.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in body weight.
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
A digital scale will be used to measure Body weight.
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in cardiovascular risk biomarkers.
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
The Alere Cholestech LDX 1 Analyzer will be used to measure Triglycerides levels.
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Changes from baseline in Walking Test.
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
A Six Minute Walking Test will be administered using standardized instructions and verbal cues
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Changes from baseline in 1-minute sit to stand test
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
A 1-minute sit to stand test will be administered using standardized instructions and verbal cues
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Changes from baseline Physical Activity
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Physical Activity and Disability Survey-Revised will be administered to assess physical function. Higher scores on the Physical Activity and Disability Survey-Revised indicates increased physical activity levels. Score range: Not applicable.
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Changes from baseline Self-efficacy for weight management
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Weight Efficacy Lifestyle Questionnaire-Short Form (WEL-SF) will be administered. A higher score on the weight efficacy lifestyle questionnaire indicates more confidence to engage in a healthy behavior (possible score range for self-efficacy weight is 1 to 10)
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Changes from baseline social support for physical activity from family
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Social Support for Exercise Behavior scales will be administered. A higher score on social support scales indicates greater social support from family to engage in physical activity (possible score range is 1 to 5).
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Changes from baseline in emotional well-being
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
Quality of Life in Neurological Disorders (Neuro-Qol) positive affect & wellbeing questionnaires will be administered. Higher scores on Quality of Life in Neurological Disorders (Neuro-Qol) positive affect and well-being indicates a greater life satisfaction (possible score range 9 to 45).
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthew A Plow, PhD, Case Western Reserve University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

January 23, 2013

First Submitted That Met QC Criteria

January 23, 2013

First Posted (Estimate)

January 25, 2013

Study Record Updates

Last Update Posted (Actual)

January 24, 2022

Last Update Submitted That Met QC Criteria

January 18, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on SystemCHANGE Group Lifestyle counseling

Subscribe